Festival of Biologics 2026 has ended. This guide stays up as the record of who was there. Next: Festival of Biologics 2027, Oct 5–7, 2027 in Basel
Therapeutic vaccines at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
13 organizations at Festival of Biologics 2026 present work in therapeutic vaccines: 5 academic, government and non-profit bodies, 4 drug developers and 4 suppliers and service providers. Between them they bring 13 presentations to the program. Most represented: Transgene, Bridges Initiative for Vaccine Regulatory Science and Practice and Genevation. As of Sep 26, 2026.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
Develops viral vector-based immunotherapies, including individualized neoantigen cancer vaccines and oncolytic viruses. | Panel Tue Oct 13 12:20 |
Chair Tue Oct 13 14:05 Talk Tue Oct 13 17:10 Misaligned Decisions in Vaccine Regulation: A Hidden Driver of Delay and What Sponsors Can Do About It How developers who misread regulators' unstated reasoning face rework and delays in vaccine programs, and practical ways to avoid it. | |
Talk Tue Oct 13 14:10 | |
Talk Tue Oct 13 17:10 Talk Wed Oct 14 14:30 Filtering for Safety First: FasTarg — a Bioinformatics-, AI- and ML-Based Target Discovery Platform for Solid Tumour TCEs How AI and bioinformatics pick tumor-only targets to make T cell engagers, antibodies that recruit T cells, safer for solid tumors. | |
Amsterdam UMC Amsterdam, Netherlands | |
Talk Tue Oct 13 17:30 APC-targeted immune-priming technology using sdAb for cancer therapy How small single-domain antibodies deliver cancer antigens to antigen-presenting cells to spark stronger T cell responses against tumors. | |
IN Istituto Nazionale Tumori Pascale Naples, Italy | |
Talk Tue Oct 13 15:30 | |
NB NEC Bio | |
Talk Tue Oct 13 14:50 Personalised oral bacteria-based DNA vaccines in early and later-stage cancer patients How personalized DNA cancer vaccines delivered by swallowed bacteria target each patient's tumor mutations, with response tracked by tumor DNA in blood. | |
University of Oxford Oxford, United Kingdom | |
Talk Tue Oct 13 16:50 | |
Université de Montréal Montreal, Canada | |
Immunopeptidomics platform using mass spectrometry to identify peptides presented by MHC molecules. | Booth Exhibiting at Booth S10 |
Supplies specific pathogen free products and services for developing animal and human health biologics, with sites in North America and Europe. | Booth Exhibiting at Booth 190 |
Medical device company making drug delivery solutions, including the CE-marked VAX-ID device, for prophylactic and therapeutic use. | Booth Exhibiting at Booth S14 |
Vaccine CDMO within WuXi Biologics offering vaccine process development and manufacturing. | Booth Exhibiting (no floor booth listed) |
Find buyers in therapeutic vaccines
Tell us what you sell and we’ll find the people at organizations working on therapeutic vaccines most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse Festival of Biologics 2026 by
- Antibody & protein engineering 67
- AI & computational design 38
- Bispecifics & multispecifics 13
- ADCs & armed antibodies 18
- Immunotherapy & oncology 44
- Cell & gene therapy 28
- Therapeutic vaccines 13
- Peptides & GLP-1 7
- Bioprocessing & manufacturing 87
- CMC, formulation & analytics 58
- Clinical development 45
- Regulation & market access 40
Not affiliated with or endorsed by the Festival of Biologics or its organizers. Submit a correction